DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…
Kia Announces September 2025 Global Sales Results
September 2025 global sales of 268,238 units, up 7.3% Y/ySales in Korea…
Omdia Forecasts Large-Area Display Shipments to Grow 2.8% YoY in 2025, Mobile PC Displays Lead the Growth
LONDON--(BUSINESS WIRE)--#Consumer--According to the latest analysis from Omdia’s Large-area display market tracker…
Euro NCAP to Launch New SAFER TRUCKS Results
WhatLatest Euro NCAP truck safety results published online and via social media.WhenTuesday 30…
Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth
September 26, 2025 16:05 ET Â | Source: Silynxcom Ltd. Netanya, Israel, Sept.…
Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025
September 26, 2025 16:04 ET Â | Source: Maris-Tech Ltd. The company continues…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Oliva launches GeneIQ – India’s First DNA-Based Derma Clinic Application
Over 130 genes and 150 traits analysed to provide personalised skin careGeneIQ…
AV-Comparatives Publishes 2025 Endpoint Prevention & Response (EPR) Test – The Most Comprehensive Enterprise Cybersecurity Evaluation to Date
INNSBRUCK, Austria, Sept. 22, 2025 /PRNewswire/ -- AV-Comparatives, the leading independent cybersecurity…